C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
about
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotypeHuman complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)Heterogeneous nuclear ribonucleoprotein D0B is a sequence-specific DNA-binding proteinStructure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytesImmunogenicity of protein therapeutics: The key causes, consequences and challengesLipid rafts and B cell signalingHuman CD81 directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulationSaliva of Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) inhibits classical and alternative complement pathwaysHow Follicular Dendritic Cells Shape the B-Cell AntigenomeRegulation of germinal center B-cell differentiationSystemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical PathwayAdvances and Challenges of Liposome Assisted Drug DeliveryEmerging and Novel Functions of Complement Protein C1qComplement regulation of T-cell alloimmunityComplement regulation of T cell immunityEffects of complement activation on allograft injuryControl of adaptive immunity by the innate immune systemAltered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infectionComplement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centersComplement and its role in protection and pathogenesis of flavivirus infectionsA crystal structure of the complex between human complement receptor 2 and its ligand C3dOn the Functional Overlap between Complement and Anti-Microbial PeptidesThe Complement System and Antibody-Mediated Transplant RejectionFunctional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparinComplement System Part II: Role in ImmunityApoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunityTolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cellsAbsence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral responseQualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilizationInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyComplement: a key system for immune surveillance and homeostasisPorcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic.Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.Uncoupling CD21 and CD19 of the B-cell coreceptorCd19-dependent activation of Akt kinase in B-lymphocytes.Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.Lipid rafts and B-cell activation.Inhibiting complement activation on cells at the step of C3 cleavage.Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.
P2860
Q24293121-B50B2A0A-9CFE-4DFA-B597-21D142DD3C01Q24296010-28D6300F-9726-4CCC-BDC2-C11BB1E49A63Q24531392-967CFFE4-8E57-426F-AA54-B494D137EB03Q24543850-5EB13734-2718-4394-96FC-2D55296BC3D5Q24597579-48BC03E0-7821-4FC0-BB0E-5DCB3209D322Q24633296-A4FE3BCB-0783-41C0-A45B-EDB4211758A2Q24680871-3B3D3709-C213-415F-9C5B-7081DF73BA7EQ24805311-90CD4DCB-D499-4FB3-B8A3-F743C074E8A8Q26700083-50460EF2-A62A-4F14-B83E-B2252D717C44Q26742173-E11A455A-62F9-4BF6-AF4D-B62DF40C524CQ26766726-3400CCA3-99CF-42A8-B3F2-139F4A8C755FQ26768534-E69437A3-850B-443E-A84B-3E07F0D19662Q26773160-E95E3F0E-0113-409F-A0D2-F0DCB57649A2Q26801642-4DB5B230-992D-46DD-B78C-2918BE313982Q26823956-9CCE0C80-AF64-467A-AA3A-811088B4E150Q26827470-7E4516BC-16BD-419D-8D68-3C6AB36D0760Q26995453-929C4DD7-47AC-4208-93E7-A4545F5BBE68Q27026513-58724A69-1510-4E8F-847C-3512E1D5D687Q27478138-717D52B4-9498-482B-A47E-4003C3794C12Q27480895-5E91E7DA-5302-49F9-B758-C57B866130E5Q27490236-F70564F3-8EE7-465F-848D-D0DFA6F948ADQ27667612-A252F34D-8FC4-4476-8454-B0BD4B3125F5Q28082379-4129D769-359D-4396-A0F2-922E10E42A84Q28087773-82A28BCB-844B-414F-8EA1-26BF8FCC6173Q28141946-CE54617C-299C-4530-9F33-B4847EFCCDA4Q28263460-FD004AC8-E84C-470C-9A96-F93A4BAB2ACEQ28385358-88637801-9AB6-4734-9499-2041DC72B904Q28565650-EB845B7A-4D91-49BF-8477-D9EBA9719D8FQ28590125-C136EFB1-7CCB-4C2E-B3A3-57E55037ADA5Q28616251-21E32F85-C6CA-456E-A93C-891E08F39A26Q28972389-342A0BA8-24F0-42D0-B6B5-0C6EDBE4DAA0Q29615484-C832A1F0-9B32-448B-A002-B1F66E49D6B6Q30364184-BD7313D0-41A7-4DEC-9328-7755D28D3A53Q30379559-CAFECA8A-C35F-4489-B385-73046D9B72E1Q30489801-496735FC-5A0B-4A19-BF5B-A47B1C68B3CAQ31478381-FB128015-CA45-47EC-9E3B-47745F0837BBQ33302902-9822D21E-2C47-40F2-9254-924A1308372BQ33337033-AC6C65D5-DE90-423C-BF77-D6AB93AFD2BEQ33384196-C8D8E107-8694-467B-99D6-BB052AA145D9Q33402381-0C451026-39BD-4FE2-8B82-8274DD57ECC2
P2860
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@ast
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@en
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@nl
type
label
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@ast
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@en
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@nl
prefLabel
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@ast
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@en
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@nl
P2093
P3181
P1433
P1476
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
@en
P2093
D T Fearon
P W Dempsey
S Akkaraju
P304
P3181
P356
10.1126/SCIENCE.271.5247.348
P407
P577
1996-01-01T00:00:00Z